Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure

By sjmartinez • April 8, 2025

Anderson E, Choi Y, Buchsbaum RJ, Klein A, Ky B, Landsburg D, Durani U, Ruddy KJ, Yu AF, Leong D, Asnani A, Neilan TG, Ganatra S, Bloom M, Barac A, Yang EH, Deswal A, Cheng RK, Weiss M, Evens AM, Kahl B, Friedberg JW, Parsons SK, Upshaw JN. Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure. Leuk Lymphoma. 2025 Apr 8:1-10. doi: 10.1080/10428194.2025.2484367. Epub ahead of print. PMID: 40195874.

Tags: anthracycline, Cancer, Cancer survivorship, Cardiology/Epi, cardiomyopathy, cardioprotection, heart failure, Publications

Design and Rationale of the WARRIOR Ancillary Study for Coronary CT Angiographic Analysis

Tamarappoo B, Wolny R, Tomasino GF, Berman D, Handberg E, Pepine CJ, Lo MC, Budoff M, Shaw L, Shufelt C, Wei J, Gulati M, Merz[...]

Ethnic differences in left ventricular myocardial volume assessed by coronary computed tomography angiography in asymptomatic adults

Zahraee S, Beshoy I, Kinninger A, Mao SS, Budoff MJ. Ethnic differences in left ventricular myocardial volume assessed by coronary computed tomography angiography in asymptomatic[...]

A neutralizing APOA5 monoclonal antibody reduces amounts of lipoprotein lipase in capillaries and triggers hypertriglyceridemia

Yang Y, Beigneux AP, Lowe TL, Chen YQ, Xie K, Jung H, Tu Y, Yu RG, Scheithauer JL, Mehta S, Wu J, Alvarez L, Davidson[...]